LEADER 01174nam--2200409---450- 001 990000961870203316 005 20050112111422.0 010 $a88-459-0516-0 035 $a0096187 035 $aUSA010096187 035 $a(ALEPH)000096187USA01 035 $a0096187 100 $a20020214d1990----km-y0itay0103----ba 101 $aita 102 $aIT 105 $a||||||||001yy 200 1 $a<> amata perduta$fJohannes Urzidil 205 $a2. ed. 210 $aMilano$cAdelphi$d1990 215 $a267 p$d22 cm 225 2 $aBiblioteca Adelphi$v124 312 $aDie verlorene Geliebte 410 $12001$aBiblioteca Adelphi$v124 454 $12001$aDie verlorene Geliebte$948363 676 $a833.914 700 1$aURZIDIL,$bJohannes$0444484 801 0$aIT$bsalbc$gISBD 912 $a990000961870203316 951 $aVII.2.A. 58(VARIE COLL. 87/124)$b119500 LM$cVARIE COLL. 959 $aBK 969 $aUMA 979 $aPATTY$b90$c20020214$lUSA01$h1607 979 $c20020403$lUSA01$h1738 979 $aPATRY$b90$c20040406$lUSA01$h1706 979 $aCOPAT2$b90$c20050112$lUSA01$h1114 996 $aDie verlorene Geliebte$948363 997 $aUNISA LEADER 03887nam 22006135 450 001 9910865258403321 005 20240905004812.0 010 $a981-9729-54-8 024 7 $a10.1007/978-981-97-2954-8 035 $a(MiAaPQ)EBC31357836 035 $a(Au-PeEL)EBL31357836 035 $a(CKB)32170743800041 035 $a(DE-He213)978-981-97-2954-8 035 $a(OCoLC)1438947090 035 $a(EXLCZ)9932170743800041 100 $a20240530d2024 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aArtificial Intelligence in Drug Development $ePatenting and Regulatory Aspects /$fby Kavita Sharma, Padmavati Manchikanti 205 $a1st ed. 2024. 210 1$aSingapore :$cSpringer Nature Singapore :$cImprint: Springer,$d2024. 215 $a1 online resource (159 pages) 225 1 $aFrontiers of Artificial Intelligence, Ethics and Multidisciplinary Applications,$x2731-8133 311 08$a981-9729-53-X 327 $aArtificial Intelligence in Drug Development - Nature and Scope -- Analysis of AI Related Patents in the Healthcare -- Regulation of AI in Drug Development -- Policy and Regulation for AI for Indian Drug and Healthcare Industry -- Way forward for Patenting and Regulation in relation to AI. 330 $aThis book discusses how Artificial Intelligence developments have revolutionized the area of medicine and how companies use them to develop applications. While the book covers the growth of AI in medicine and the early developments in AI based medical tools, it provides an in-depth analysis of the current developments in relation to the area of medical diagnostics. The book focuses on how enterprises and institutes have developed their intellectual property portfolio, particularly patents, in this area. Cross-country patenting analysis helps in understanding key areas of growth in certain markets and also company strategies and arrangements. The introduction of AI based products in market is subject to regulation. The developments in policy and regulation influence the development and deployment of such products into the market. This book brings focus to the development of policy and regulation and how regulatory developments impact the introduction of AI-based healthcare products from a cross-country perspective. Further, how regulatory developments lead to the evolution of standards, build reliability and safety in this area are also examined. The unique aspect of this book is the comprehensive coverage of the dual aspects of the nature and scope of AI-based innovations in health care and the related drug regulatory aspects which are imperative for the understanding for students, researchers, and those who work in this area. 410 0$aFrontiers of Artificial Intelligence, Ethics and Multidisciplinary Applications,$x2731-8133 606 $aInformation technology$xLaw and legislation 606 $aMass media$xLaw and legislation 606 $aHealth services administration 606 $aArtificial intelligence 606 $aIT Law, Media Law, Intellectual Property 606 $aHealth Care Management 606 $aArtificial Intelligence 615 0$aInformation technology$xLaw and legislation. 615 0$aMass media$xLaw and legislation. 615 0$aHealth services administration. 615 0$aArtificial intelligence. 615 14$aIT Law, Media Law, Intellectual Property. 615 24$aHealth Care Management. 615 24$aArtificial Intelligence. 676 $a343.099 700 $aSharma$b Kavita$01742553 701 $aManchikanti$b Padmavati$01742554 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910865258403321 996 $aArtificial Intelligence in Drug Development$94169303 997 $aUNINA